Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
sodium benzoate
sodium phenylacetate |
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:V03AB
|
| gptkbp:form |
solution for injection
|
| gptkbp:indication |
gptkb:urea_cycle_disorders
|
| gptkbp:manufacturer |
Exela Pharma Sciences
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:usedFor |
treatment of hyperammonemia
|
| gptkbp:bfsParent |
gptkb:Argonians
gptkb:Argonian |
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Neetrenaza
|